No Detail Found!

Comparative Effects of Monosialoganglioside Versus Citicoline on Apoptotic Factor, Neurological Function and Oxidative Stress in Newborns with Hypoxic-ischemic Encephalopathy.

Author(s)
ShiPeng Liang Department of Emergency, Affiliated Children's Hospital of Zhengzhou University, Zhengzhou, 450000, China
Qian Chen Department of Clinical Medicine, Xinxiang Medical University, Xinxiang, 453003, China
YiBing Cheng Department of Emergency, Affiliated Children's Hospital of Zhengzhou University, Zhengzhou, 450000, China
Ying Ying Xue Department of Emergency, Affiliated Children's Hospital of Zhengzhou University, Zhengzhou, 450000, China
HaiJun Wang Department of Emergency, Affiliated Children's Hospital of Zhengzhou University, Zhengzhou, 450000, China
Abstract
Objective: To determine the comparative effect of monosialoganglioside versus citicoline on the content changes of serum apoptotic factors (PDCD5, sFas and sFasL), neurological function indices (BDNF, NSE, S100-b and NGF) and oxidative stress indices (SOD, MDA and GSH-PX) in newborns with hypoxic-ischemic encephalopathy (HIE). Study Design: An experimental study. Place and Duration of Study: Emergency Department, Affiliated Children's Hospital of Zhengzhou University, China, from October 2016 to February 2018. Methodology: A total of 90 newborns with HIE were randomly divided into a treatment group and a control group, with 45 cases in each group. In addition to the conventional treatment, the treatment group was given monosialoganglioside treatment, while the control group was given citicoline treatment. Both groups were treated for 10 days. After treatment, the content differences of serum apoptosis factors (PDCD5, sFas and sFasL), neurological function indices (BDNF, NSE, S100-b and NGF) and oxidative stress indices (SOD, MDA and GSH-PX) were observed in the two groups. Results: After treatment, the levels of serum PDCD5, sFas, sFasL, MDA, NSE and S100-b in the treatment group were lower than those in the control group (all p<0.001). The contents of serum SOD, GSH-PX, BDNF and NGF in the treatment group were higher than those in the control group (all p<0.001). Conclusion: Monosialoganglioside can effectively improve the apoptotic factors, neurological function and oxidative stress indices in newborns and maintain the stability of the internal environment, so it is worthy of promotion and application.
Publication Details
Page(s) 324-327
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 29, Issue: 4, Year: 2019

Request the full text from PASTIC

References
WeemsMF,UpadhyayK,SandhuHS, 2018.Survey of ECMO practices for infants with hypoxic ischemic encephalopathy,J Perinatol 38 1197 -204
ButtTK,FarooquiR,KhanMA, 2008.Risk factors for hypoxic ischemic encephalopathy in children,J Coll Physicians Surg Pak 18 428 -32
ItooBA,Al-HawsawiZM,KhanAH, 2003.Hypoxic ischemic encephalopathy. Incidence and risk factors in North Western Saudi Arabia,Saudi Med J 24 147 -53
MartinelloK,HartAR,YapS,MitraS,RobertsonNJ, 2017.Management and investigation of neonatal encephalopathy: 2017 update,Arch Dis Child Fetal Neonatal Ed 102 F346 -58
ChalakL,LatremouilleS,MirI,SánchezPJ,Sant'Anna G, 2018.A review of the conundrum of mild hypoxic-ischemic encephalopathy: Current challenges and moving forward,Early Hum Dev 120 88 -94
AhmadQM,ChishtiAL,WaseemN., 2018.Role of melatonin in management of hypoxic ischaemic encephalopathy in newborns: A randomized control trial,J Pak Med Assoc 68 1233 -7
ErtlM,WeberS,HammelG,SchroederC, 2018.Transorbital sonography for early prognostication of hypoxicischemic encephalopathy after cardiac arrest,J Neuroimaging 28 542 -8
LuJ,YaoXQ,LuoX,WangY,ChungSK,TangHX, 2017.Monosialoganglioside 1 may alleviate neurotoxicity induced by propofol combined with remifentanil in neural stem cells,Neural Regen Res 12 945 -52
LiS,XiaoN,ZhangX,LiuL,LinL,ChenS, 2008.Effects of exogenous ganglioside-1 on learning and memory in a neonatal rat model of hypoxia-ischemia brain injury,Neural Regen Res 3 1004 -9
CohenRA,BrowndykeJN,MoserDJ,PaulRH,GordonN,SweetL, 2003.Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes,Cerebrovasc Dis 16 199 -204
ConantR,SchaussAG, 2004.Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: A review of the literature,Altern Med Rev 9 17 -31
GiménezR,SolerS,AguilarJ, 1999.Cytidine diphosphate choline administration activates brain cytidine triphosphate: phosphocholine cytidylytransferase in aged rats,Neurosci Lett 273 163 -6
SamsonJC., 1990.GM1 ganglioside treatment of central nervous system injury: Clinical evidence for improved recovery,Drug Develop Res 19 209 -24
Stephen D. Skaper , Alberta Leon, Gino,Toffano, 1989.Ganglioside function in the development and repair of the nervous system,Mol Neurobiol 3 173 -99
SkaperSD,LeonA, 1992.Monosialogangliosides, neuroprotection, and neuronal repair processes,J Neurotrauma 9 S507 -16
Abou-AbbassH,BahmadH,Abou-El-HassanH,ZhuR,ZhouS,DongX, 2016.Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment,Electrophoresis 37 1562 -76
ShengL,LiZ., 2017.Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxicischemic encephalopathy: A meta-analysis of randomized controlled trials,PloS One 12 e0183490 -
TracyCM,GrayAJ,CuéllarJ,ShawTS,HowlettAC,TaylorRM, 2014.Programmed cell death protein 5 interacts with the cytosolic chaperonin containing tailless complex polypeptide 1 (CCT) to regulate tubulin folding,J Biol Chem 289 4490 -502
FacciL,LeonA,SkaperSD, 1990.Hypoglycemic neurotoxicity in vitro: involvement of excitatory amino acid receptors and attenuation by monosialoganglioside GM1,Neuroscience 37 709 -16
OliveiraNK,FerreiraRN,LopesS,ChiariE,CamargosE,MartinelliPM, 2017.Cardiac autonomic denervation and expression of neurotrophins (NGFand BDNF) and their receptors during experimental chagas disease,Growth Factors 35 161 -70
GorriaM,HucL,SergentO,RebillardA,GaboriauF,Dimanche-BoitrelMT, 2006.Protective effect of monosialoganglioside gm1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport,Biochem Pharmacol 72 1343 -53
SinghSK,DuaT,TandonA,KumariS,RayG,BatraS., 1999.Status of lipid peroxidation and antioxidant enzymes in hypoxic ischemic encephalopathy,Indian Pediatr 36 561 -6
0

Citations

0

Downloads

62

Views